New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
10:00 EDTWAG, CVS, ABC, MCK, CTRX, ESRX, CAHLeerink's healthcare tech analyst holds an analyst/industry conference call
Healthcare Technology Analyst Larsen, along with MEDACorp Specialists Brian Anderson and Mary Beth Mulligan, discuss the quality of service and performance provided by each PBM (Pharmacy Benefit Manager) on an Analyst/Industry conference call. Relevant companies ABC, CAH, CTRX, CVS, ESRX, MCK and WAG may be included on the Analyst/Industry conference call to be held on March 31 at 11 am.
News For ABC;CAH;CTRX;CVS;ESRX;MCK;WAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
08:31 EDTMCKOmnicare, McKesson expand distribution agreement
Omnicare (OCR) and McKesson Corporation (MCK) announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. The new five year agreement, which extends through December 2019, creates efficiencies for both companies by leveraging the strength of Omnicare as the nationís largest institutional pharmacy and a leading specialty pharmaceutical services provider and McKesson as a global leader in pharmaceutical sourcing and supply chain management. Omnicare noted that it believes the benefits of its new sourcing strategy will be a key driver in enabling it to generate a low double-digit adjusted cash EPS growth rate in 2015.
07:33 EDTMCKBrean Capital to hold a summit
Subscribe for More Information
November 21, 2014
10:00 EDTABCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:32 EDTABCAmerisourceBergen downgraded to Market Perform at FBR Capital
FBR Capital downgraded AmerisourceBergen to Market Perform from Outperform saying the stock's valuation reflects the company's long-term growth prospects. FBR keeps a $90 price target on shares.
07:08 EDTCAHHenry Schein, Cardinal Health Enter long-term strategic agreement
Cardinal Health (CAH) and Henry Schein (HSIC) announced that the companies have entered into a long-term strategic agreement to provide one of the most comprehensive service and product offerings to office-based medical practices. This strategic agreement combines Cardinal Health's product line and extensive touch points across the health system with Henry Schein's outstanding service capabilities and history in serving office-based practices. Under the terms of the agreement, the physician office-focused commercial organization of Cardinal Health's Medical segment will be consolidated into the commercial organization of Henry Schein's Medical Group. Henry Schein has committed to purchase Cardinal Health Brand products and utilize Cardinal Health as a primary source for various medical products.
06:15 EDTABCAmerisourceBergen downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
November 17, 2014
08:37 EDTCAHCardinal Health management to meet with FBR Capital
Meetings to be held in the Midwest November 17-18 hosted by FBR Capital.
07:00 EDTMCKNovaBay signs distribution agreement with McKesson
NovaBay (NBY) has signed a nationwide distribution agreement with McKesson Corporation (MCK). The agreement covers NovaBayís i-LidTM Cleanser, a prescription lid and lash hygiene product for the management of debilitating eye conditions such as blepharitis, Meibomian gland dysfunction and associated dry eye.
November 14, 2014
16:39 EDTESRXBerkshire Hathaway gives quarterly update on stakes
Subscribe for More Information
14:53 EDTCVS, ESRXCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
07:14 EDTMCKAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use